Navigation Links
ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
Date:1/8/2009

at this first dose tested in the Phase Ib study," commented James Freddo, M.D., Anadys' Senior Vice President, Drug Development and Chief Medical Officer. "We believe this early data continues to position ANA598 as a leading non-nucleoside polymerase inhibitor in development for the treatment of HCV and we look forward to investigating ANA598 in longer-term studies in combination with current standard of care."

"The clinical and preclinical profile of ANA598 observed to date is very impressive," said Steve Worland, Ph.D., President and CEO of Anadys. "The magnitude of viral load drop reported today for ANA598 is greater than has been reported for any other non-nucleoside HCV inhibitor in a monotherapy study. Furthermore, the rate of initial viral load decline, believed to be associated with direct inhibition of viral replication, is greater than has been reported previously for all classes of HCV polymerase inhibitors, including nucleosides. This demonstrated antiviral potency holds significant promise for the future use of ANA598 in combination with other anti-HCV agents."

About ANA598

Anadys retains worldwide rights to ANA598, which was fully discovered at the Company. Preclinical evaluation of ANA598 was completed in the first quarter of 2008, leading to submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA), subsequent allowance of the IND by the FDA and initiation of clinical investigation in the second quarter of 2008. In December 2008, Anadys announced that the FDA granted fast track designation to ANA598 for the treatment of chronic HCV.

In October 2008, Anadys initiated patient dosing in the Phase Ib study of ANA598 in HCV patients. In the double-blind, randomized placebo-controlled Phase Ib study, treatment-naive genotype 1a and 1b patients are to receive oral capsules of ANA598 over three days at doses of 200 mg bid (twice
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
8. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)...  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... chronic inflammatory disease and neurologic disorders, announced today ... U.S. Food and Drug Administration (FDA) in response ... the formulations of Anatabloc® and CigRx® submitted by the ... FDA considers anatabine citrate, a principal ingredient in ...
(Date:9/11/2014)... , September 11, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/lqkmlx/radio_frequency ) has announced the ... Identification (RFID) Market in Healthcare (Tags, ... Industry Analysis, Size, Share, Growth, Trends ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
(Date:9/11/2014)... Intarcia Therapeutics, Inc. today announced its participation in ... Association for the Study of Diabetes (EASD), taking place ... lead product candidate, ITCA 650, (exenatide, delivered continuously through ... global Phase 3 trials and could become the first ... 2 diabetes. Intarcia,s global ITCA 650 phase 3 ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 2Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 3Global Radio Frequency Identification (RFID) Market in Healthcare (Tags, Readers, Middleware, Printers and Cabinets) - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2020 2Global Radio Frequency Identification (RFID) Market in Healthcare (Tags, Readers, Middleware, Printers and Cabinets) - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2020 3Intarcia Announces Two Presentations At 50th EASD Meeting: Confirms Pivotal Phase 3 Data Announcement For ITCA 650 In Type 2 Diabetes In 4Q 2Intarcia Announces Two Presentations At 50th EASD Meeting: Confirms Pivotal Phase 3 Data Announcement For ITCA 650 In Type 2 Diabetes In 4Q 3Intarcia Announces Two Presentations At 50th EASD Meeting: Confirms Pivotal Phase 3 Data Announcement For ITCA 650 In Type 2 Diabetes In 4Q 4
... CITY, April 14, 2011 Booth #H1/E32 -- Varian Medical ... selection of X-ray tubes and flat panel image detectors for ... (CMEF) meeting in Shenzhen, China, April 16-18, 2011.  Varian will ... radiosurgery. Varian,s exhibit will showcase: ...
... Richmond Ambulance Authority (RAA) and Bon Secours Virginia ... launched a new program designed to save the lives ... cards that will help first responders provide rapid and ... (Photo: http://photos.prnewswire.com/prnh/20110414/PH82953 ) ...
Cached Medicine Technology:Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China 2Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China 3Richmond Launches Nation's First Rider Alert Cards for Motorcyclists 2
(Date:9/13/2014)... 2014 Top10BestSEOHosting.com is a well-known ... a lot of web hosting suppliers and announced ... are the best ASP.NET hosting suppliers in 2014. ... hosting is a very popular way for webmasters ... The IT manager is happy to introduce Arvixe, ...
(Date:9/13/2014)... Happiness is a choice that can transform lives and ... what LWell believes thanks to Joana U-Ming Stephens. ... coach who has loved fitness and has been practicing holistic ... is a Choice" seminar at its Yorktown, Va. location Friday, ... is being offered free as a gift to the community ...
(Date:9/13/2014)... Baltimore, MD (PRWEB) September 13, 2014 Deaf ... year The Hearing and Speech Agency hosts a ... American Sign Language (ASL) as the main form of ... year, the schedule includes an ASL film night, a yoga ... is open to the entire community. , The schedule is ...
(Date:9/13/2014)... 13, 2014 Motion Graphics artist at Pixel ... pack entitled TransPack Volume 2 exclusively for Final Cut Pro ... to transition from one clip to the next.” Said Christina ... have too many transition options and TransPack Volume 2’s professional ... 2 is a package of 30 thematic transitions made specifically ...
(Date:9/13/2014)... Salt Lake City, Utah (PRWEB) September 13, 2014 ... hot topic in Utah. Coming into mosquito high season ... Hurricane, Cedar City and surrounding areas. With a rise ... County’s Sean Amodt is facilitating a partnership with Dixie ... and Associates for testing on a product called NutriVex. ...
Breaking Medicine News(10 mins):Health News:Best ASP.NET Hosting Suppliers in 2014 Unveiled By Top10BestSEOHosting.com 2Health News:“Happiness is a Choice” Life Coaching Seminar Open to Community 2Health News:“Happiness is a Choice” Life Coaching Seminar Open to Community 3Health News:Baltimore Nonprofit Celebrates Deaf Awareness Week 2Health News:Baltimore Nonprofit Celebrates Deaf Awareness Week 3Health News:Today a new TransPack Volume 2 transition was announced from Pixel Film Studios for Final Cut Pro X. 2Health News:Dixie State University Partners with Utah Marketing Firm and the SW Mosquito Abatement and Control District for Product Testing 2Health News:Dixie State University Partners with Utah Marketing Firm and the SW Mosquito Abatement and Control District for Product Testing 3
... Science and Technology Kapil Sibal today told captains of the ... that the industry projected in the sector, may not be ... never happen. It is a far cry,' Sibal said at ... as India's biggest biotech show., ,Unlike the IT sector ...
... signals transmitted to Earth by extraterrestrials by a new ... amount of sky covered by current equipment -according to ... exploration and funding the telescope's development are the Planetary ... alien civilizations, whom use light signals to communicate as ...
... Football fans who spend hours guzzling beer while watching the ... not being man enough to play the game, says a ... of Sussex claim that men who are not confident of ... try and prove their masculinity., ,The study, based on ...
... treatment mode for women diagnosed with breast cancer who harbour ... consider hormonal treatments to reduce their risk of a revival. ... led by researchers at the University of Michigan Comprehensive Cancer ... mutation who had their ovaries removed or took the anti-estrogen ...
... among Africans as a custom rather than as a matter ... curbing sexual waywardness //in the females while some clans even ... method of initiating teenage girls into adulthood. ,As ... and scissors which are often unsterilized. In addition the area ...
... calpain can play a key role in regulating cell death, ... by these scientists //that calpain may be used to promote ... prevent cell death such as in neuronal cells in ... a Professor of Pathology and Molecular Medicine with the Cancer ...
Cached Medicine News:Health News:Breast-Sparing Surgery: An Optional Treatment Mode For Women With Breast Cancer 2Health News:Breast-Sparing Surgery: An Optional Treatment Mode For Women With Breast Cancer 3Health News:Female Circumcision Rampant in Africa 2Health News:Protein’s role in regulating cell death sets direction for Alzheimer’s, Parkinson’s and cancer resea 2
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: